15Oct
Allspring Global Investments Holdings LLC Has $10.66 Million Stock Position in Keysight Technologies, Inc. (NYSE:KEYS)

Allspring Global Investments Holdings LLC trimmed its position in Keysight Technologies, Inc. (NYSE:KEYS – Get Rating) by 15.9% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 77,328 shares of the scientific and technical instruments company’s stock after selling 14,625 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Keysight Technologies were worth $10,658,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Geneos Wealth Management Inc. lifted its stake in shares of Keysight Technologies by 37.1% in the second quarter. Geneos Wealth Management Inc. now owns 277 shares of the scientific and technical instruments company’s stock worth $37,000 after buying an additional 75 shares during the last quarter. Los Angeles Capital Management LLC lifted its stake in shares of Keysight Technologies by 2.8% in the first quarter. Los Angeles Capital Management LLC now owns 2,859 shares of the scientific and technical instruments company’s stock worth $452,000 after buying an additional 77 shares during the last quarter. TCI Wealth Advisors Inc. lifted its stake in shares

…
14Sep
Duck Creek Technologies (NASDAQ:DCT) Sees Unusually-High Trading Volume

Shares of Duck Creek Technologies, Inc. (NASDAQ:DCT – Get Rating) saw strong trading volume on Monday . 21,954 shares changed hands during mid-day trading, a decline of 97% from the previous session’s volume of 823,367 shares. The stock last traded at $11.95 and had previously closed at $11.65.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. DA Davidson cut their price objective on Duck Creek Technologies to $30.00 in a research report on Monday, July 4th. Royal Bank of Canada lowered Duck Creek Technologies from an “outperform” rating to a “sector perform” rating and dropped their price target for the company from $18.00 to $14.00 in a research report on Tuesday, July 19th. JMP Securities lowered Duck Creek Technologies from an “outperform” rating to a “market perform” rating in a research report on Friday, July 1st. Raymond James dropped their price target on Duck Creek Technologies from $24.00 to $18.00 and set an “outperform” rating on the stock in a research report on Thursday, June 30th. Finally, Bank of America lowered Duck Creek Technologies from a “buy” rating to a “neutral” rating and dropped their price target for the company from $39.00

…
4Sep
Dynavax Technologies (NASDAQ:DVAX) Cut to C+ at TheStreet

TheStreet cut shares of Dynavax Technologies (NASDAQ:DVAX – Get Rating) from a b- rating to a c+ rating in a report released on Thursday morning, TheStreetRatingsTable reports.

Separately, StockNews.com upgraded Dynavax Technologies from a hold rating to a buy rating in a report on Friday, August 5th. One equities research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of Moderate Buy and a consensus price target of $28.00.

Dynavax Technologies Stock Performance

Dynavax Technologies stock opened at $11.21 on Thursday. The stock’s 50-day moving average is $13.86 and its 200-day moving average is $11.89. The company has a market cap of $1.42 billion, a price-to-earnings ratio of 8.01 and a beta of 1.30. The company has a debt-to-equity ratio of 0.52, a current ratio of 2.77 and a quick ratio of 2.55. Dynavax Technologies has a 12 month low of $7.26 and a 12 month high of $21.39.

Insider Activity at Dynavax Technologies

Want More Great Investing Ideas?

In related news, SVP Robert Janssen sold 7,938 shares of the firm’s stock in a transaction dated Tuesday, August 9th.

…
5Aug
Borqs Applied sciences (NASDAQ:BRQS) Share Worth Crosses Beneath Fifty Day Transferring Common of $2.75

Shares of Borqs Applied sciences, Inc. (NASDAQ:BRQS – Get Score) handed under its 50 day shifting common throughout buying and selling on Thursday . The inventory has a 50 day shifting common of $2.75 and traded as little as $1.26. Borqs Applied sciences shares final traded at $1.27, with a quantity of 5,367,654 shares traded.

Borqs Applied sciences Buying and selling Down 8.6%

The enterprise has a fifty day easy shifting common of $2.75 and a two-hundred day easy shifting common of $3.77.

Institutional Inflows and Outflows

A hedge fund not too long ago raised its stake in Borqs Applied sciences inventory. Virtu Monetary LLC grew its place in shares of Borqs Applied sciences, Inc. (NASDAQ:BRQS – Get Score) by 170.3% throughout the first quarter, in response to its most up-to-date submitting with the SEC. The agency owned 598,798 shares of the corporate’s inventory after buying a further 377,286 shares throughout the interval. Virtu Monetary LLC owned about 0.52% of Borqs Applied sciences price $131,000 on the finish of the latest quarter. 7.39% of the inventory is at the moment owned by institutional traders and hedge funds.

About Borqs Applied sciences

(Get Score)

Borqs Applied sciences, Inc supplies Android-based sensible

…
1Aug
Shoals Applied sciences Group, Inc. (NASDAQ:SHLS) Receives Common Suggestion of “Reasonable Purchase” from Analysts

Shoals Applied sciences Group, Inc. (NASDAQ:SHLS – Get Ranking) has obtained a mean ranking of “Maintain” from the fourteen analysis corporations which can be masking the agency, Marketbeat Scores stories. 5 analysis analysts have rated the inventory with a maintain suggestion and 4 have issued a purchase suggestion on the corporate. The common 12 month goal worth amongst brokerages which have lined the inventory within the final 12 months is $25.92.

A lot of brokerages have issued stories on SHLS. UBS Group elevated their worth goal on Shoals Applied sciences Group to $27.00 in a analysis word on Thursday, June ninth. Oppenheimer dropped their worth goal on shares of Shoals Applied sciences Group to $40.00 and set a “na” ranking on the inventory in a analysis word on Tuesday, Might seventeenth. Cowen lowered their worth goal on Shoals Applied sciences Group to $20.00 and set a “na” ranking on the inventory in a analysis report on Tuesday, Might seventeenth. The Goldman Sachs Group raised their worth goal on Shoals Applied sciences Group from $19.00 to $22.00 and gave the corporate a “purchase” ranking in a analysis report on Monday, June twentieth. Lastly, Northland Securities downgraded Shoals Applied sciences Group from

…
26Jul
It took months for a physician to take my signs critically

This First Individual article is the expertise of Negin Nia who lives in Vancouver. For extra details about CBC’s First Individual tales, please see the FAQ.

I used to be mendacity on a gurney within the hallway of the hospital basement. It was December 2020. BC was seeing lots of of circumstances of COVID-19 every day and hospitalizations had been additionally rising. I had a blue hospital robe and surgical masks on, and I waited anxiously to be wheeled into the room the place my ultrasound can be performed.

Though I used to be an in any other case wholesome 22-year-old, I had a coronary heart situation referred to as mitral valve prolapse — a elaborate manner of claiming considered one of my coronary heart valves didn’t shut correctly. And only a few days in the past, I had emergency open-heart surgical procedure.

My nurses had informed me I used to be on the highest danger of an infection within the days proper after my operation, so the hospital was the final place I needed to be. However I wanted this scan to see the outcomes of my surgical procedure, and so I waited anxiously.

Lastly, a masked nurse

…
25Jul
Canadians who received pandemic pets say they’ve skilled psychological well being advantages

Spike was a tiny pet, virtually sufficiently small to slot in one hand, when Laurie Brooke introduced him house in Could 2021, however he had an unlimited influence on her life from the second he arrived.

Even earlier than the pandemic, Brooke struggled with melancholy and nervousness, and he or she found having Spike was an excellent addition to her common remedy.

“He is like a instrument in my psychological well being toolbox,” stated Brooke, who lives in Toronto.

Simply holding the little Yorkshire terrier and searching into his eyes helped her to focus and be within the second when she was feeling careworn.

“He simply jogs my memory to be current, to be right here to be with him, to be glad.”

Spike additionally helped her with social nervousness. Whereas enjoying fetch, he would carry the ball to strangers to throw for him, forcing Brooke to work together with different folks.

It was an identical expertise for Andrea Kovacs, who received her pet Violet, a golden retriever, after transferring from Burlington, Ont., to North Vancouver in the course of the pandemic.

Woman poses with dog.
Andrea Kovacs, who moved from Burlington, Ont., to Vancouver, says her golden retriever Violet helped her see the
…
22Jul
Maxar Applied sciences Inc. (NYSE:MAXR) Receives Consensus Ranking of “Average Purchase” from Analysts

Maxar Applied sciences Inc. (NYSE:MAXR – Get Ranking) has obtained a consensus suggestion of “Average Purchase” from the fifteen brokerages which might be masking the corporate, Marketbeat experiences. One analysis analyst has rated the inventory with a promote ranking, three have issued a maintain ranking and eight have assigned a purchase ranking to the corporate. The typical 12-month value goal amongst brokerages which have issued a report on the inventory within the final 12 months is $38.93.

Various analysis analysts not too long ago weighed in on the inventory. TD Securities raised their value goal on shares of Maxar Applied sciences from $43.00 to $45.00 and gave the corporate a “purchase” ranking in a analysis notice on Thursday, Could twenty sixth. Canaccord Genuity Group raised their value goal on shares of Maxar Applied sciences to $40.00 and gave the corporate a “purchase” ranking in a analysis notice on Wednesday, Could twenty fifth. Citigroup raised shares of Maxar Applied sciences from a “maintain” ranking to a “purchase” ranking and decreased their value goal for the corporate from $42.00 to $38.00 in a analysis notice on Tuesday, Could tenth. They famous that the transfer was a valuation name. Financial institution of America

…